Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 3.

Journal Article

Beer, Andrea, Holzmann, Heidemarie, Pischke, Sven, Behrendt, Patrick, Wrba, Fritz, Schlue, Jerome, Drebber, Uta, Neudert, Barbara, Halilbasic, Emina, Kreipe, Hans, Lohse, Ansgar, Sterneck, Martina, Wedemeyer, Heiner, Manns, Michael and Dienes, Hans P. (2019). Chronic Hepatitis E is associated with cholangitis. Liver Int., 39 (10). S. 1876 - 1884. HOBOKEN: WILEY. ISSN 1478-3231

Traussnigg, Stefan, Schattenberg, Jorn M. ORCID: 0000-0002-4224-4703, Demir, Muenevver, Wiegand, Johannes, Geier, Andreas, Teuber, Gerlinde, Hofmann, Wolf Peter, Kremer, Andreas E., Spreda, Frank, Kluwe, Johannes, Petersen, Joerg, Boettler, Tobias ORCID: 0000-0002-1195-055X, Halilbasic, Emina, Greinwald, Roland, Proels, Markus, Manns, Michael P., Fickert, Peter and Trauner, Michael H. (2017). norUrsodeoxycholic acid (norUDCA) improves non-alcoholic fatty liver disease (NAFLD): Results from a randomized placebo-controlled, double-blind phase IIa study. Hepatology, 66. S. 106A - 108. HOBOKEN: WILEY. ISSN 1527-3350

Traussnigg, Stefan, Schattenberg, Jorn M. ORCID: 0000-0002-4224-4703, Demir, Munevver, Wiegand, Johannes, Geier, Andreas, Teuber, Gerfinde, Hofmann, Wolf Peter, Kremer, Andreas E., Spreda, Frank, Kluwe, Johannes, Petersen, Jorg, Boettler, Tobias ORCID: 0000-0002-1195-055X, Rainer, Florian, Halilbasic, Emina, Greinwald, Roland, Prols, Markus, Manns, Michael P., Fickert, Peter and Trauner, Michael ORCID: 0000-0002-1275-6425 (2019). Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial. Lancet Gastroenterol. Hepatol., 4 (10). S. 781 - 794. SAN DIEGO: ELSEVIER INC. ISSN 2468-1253

This list was generated on Sat Oct 23 04:13:31 2021 CEST.